alogliptin benzoate

alogliptin benzoate (VIPIDIA) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

VIPIDIA is a marketed brand name for alogliptin benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

alogliptin benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.